Les resultats insuffisants de la radiochimiotherapie conventionnelle dans les cancers bronchiques non a petites cellules (CBNPC) ont motive l’evaluation d’une nouvelle strategie de modulation pharmacologique de la radiosensibilite tumorale basee sur
PDF) Evaluation préclinique d'une nouvelle stratégie de radiosensibilisation pharmacologique : l'inhibition des histones désacétylases
Frontiers Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy
IJMS, Free Full-Text
PDF) Radio-immunothérapie par antigène carcino embryonnaire (ACE) marqué à l'iode 131I-labetuzumab après chirurgie de sauvetage des métastases hépatiques de cancer colorectal
Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect
Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect
IJMS, Free Full-Text
Epigenetic modulation of secondary metabolite profiles in Aspergillus calidoustus and Aspergillus westerdijkiae through histone deacetylase (HDAC) inhibition by vorinostat
Frontiers Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy
Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect
Frontiers Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors